Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.75
0.00 (0.00%)
Aug 21, 2026, 1:31 PM CST

TPEX:4431 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.32-16.6-82.38-56.22-91.9-14.01
Depreciation & Amortization
64.1369.7389.7191.29102.4850.6
Other Amortization
445.765.74.03-
Loss (Gain) From Sale of Assets
4.232.77-17.514.1-8.680.16
Asset Writedown & Restructuring Costs
1.261.2641.65-0.9251.4725.65
Loss (Gain) From Sale of Investments
------33.34
Loss (Gain) on Equity Investments
-1.23-1.080.26-0.94-1.660.86
Stock-Based Compensation
------2.9
Provision & Write-off of Bad Debts
-7.750.140.681.27-0.12-0.02
Other Operating Activities
-11.89-12.93-6.29-8.1917.99-74.51
Change in Accounts Receivable
20.6713.3623.52-55.7818.5245.13
Change in Inventory
-20.51-9.892.26-18.643.4741.96
Change in Accounts Payable
164.07132.2153.6171-8.42-3.4
Change in Unearned Revenue
-1.950.49-1.331.05-1.27-2.43
Change in Other Net Operating Assets
13.1317.05-78.31-37.97-13.43-20.47
Operating Cash Flow
222.84200.531.63-4.2672.4813.29
Operating Cash Flow Growth
-533.90%--445.52%-96.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.78-4.33-8.88-21.77-35.5-29.75
Sale of Property, Plant & Equipment
0.310.3149.92.389.592.4
Cash Acquisitions
----230--
Sale (Purchase) of Intangibles
-0.12-1.49-6.16-3.24-7.81-0.59
Investment in Securities
11.11-118.519.59--52.2412.81
Other Investing Activities
4.079.338.92-15.66-1.95-15.95
Investing Cash Flow
10.59-114.6863.36-268.29-87.91-31.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--3.6244.2112.52-
Long-Term Debt Issued
--2.55116.3--
Total Debt Issued
-8.67-6.17160.5112.52-
Short-Term Debt Repaid
--3.52----109.03
Long-Term Debt Repaid
--53.61-51.59-155.36-55.54-10.46
Total Debt Repaid
-63.32-57.13-51.59-155.36-55.54-119.5
Net Debt Issued (Repaid)
-71.99-57.13-45.425.15-43.02-119.5
Common Dividends Paid
------121.79
Other Financing Activities
-1.11-0.625.040.26-16.82-
Financing Cash Flow
-73.11-57.74-40.385.41-59.84-241.28

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.39-2.471.75-0.742.08-5.02
Net Cash Flow
161.7125.6156.36-267.87-73.2-264.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
218.06196.1722.75-26.0336.98-16.46
Free Cash Flow Growth
-762.17%----
Free Cash Flow Margin
10.62%10.09%1.29%-2.01%2.51%-5.64%
Free Cash Flow Per Share
5.865.370.62-0.711.01-0.45
Levered Free Cash Flow
209.92194.8427-18.4117.75-5.09
Unlevered Free Cash Flow
212.41198.0130.83-14.5321-4.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.095.096.166.345.241.66
Cash Income Tax Paid
0.180.183.397.4811.0279.49
Change in Working Capital
175.41153.23-0.26-40.34-1.1360.79